Build, Buy, or Blend: How Life Sciences Commercial Teams Should Approach AI Platform Strategy

Why You Should Attend

• Understand the Build vs. Buy vs. Blend framework for evaluating AI platforms in life sciences insights and analytics

• Identify common pitfalls that delay value realization, such as data readiness, integration complexity, and internal resource constraints

• Learn how life sciences teams are accelerating time-to-insight using AI

• Discover how to ensure AI initiatives drive real business decisions, not just dashboards

Who Should Attend

Senior leaders and decision-makers across the following key areas:

• Customer Insights & Market Research
  

• Commercial Analytics & Data Science  

• Commercial Operations / Business Excellence

• Medical Affairs

• Brand / Franchise Strategy

• Digital & Omnichannel Strategy

• Market Access

• AI Strategy, Governance & Enablement

• IT & Data Platform Leadership

What We’ll Cover

• The Build vs. Buy vs. Blend models for implementing AI in life sciences organizations

• Key trade-offs organizations should consider when selecting an AI approach

• Common challenges slowing AI adoption across commercial teams

• A practical decision framework to help evaluate and implement the right AI strategy